For the Inventor, By the Inventor

Enter inventor name

San Diego, CA, United States of America

Laura Marjorie Walker

USPTO Granted Patents = 10 (Patent Applications = 4)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 12.2

ph-index = 2

Forward Citations = 31(Granted Patents)

Company Filing History:

Theraclone Sciences, Inc.

10 out of 1,187

The Scripps Research Institute

International Aids Vaccine Initiative

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

Loading Chart...

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312396 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2025-05-27),

2. 12018067 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2024-06-25),

3. 11584789 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2023-02-21),

4. 11319362 - Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies (2022-05-03),

5. 10865234 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2020-12-15),

6. 10407493 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2019-09-10),

7. 10239934 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2019-03-26),

8. 9920111 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2018-03-20),

9. 9464131 - Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody (2016-10-11),

10. 9051362 - Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity (2015-06-09),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…